This document discusses contrast-induced nephropathy (CIN). It describes the types of contrast agents used, risk factors for CIN, methods for prevention including volume expansion with intravenous or oral hydration, and diagnostic criteria for CIN. The nephrotoxic effects of contrast agents increase with higher osmolality, larger volume, repeated or intra-arterial administration, and can be prevented through adequate hydration before and after exposure.